OA10153A - Compositions of oak bark extract related synthetic compositions and method of using same - Google Patents
Compositions of oak bark extract related synthetic compositions and method of using same Download PDFInfo
- Publication number
- OA10153A OA10153A OA60657A OA60657A OA10153A OA 10153 A OA10153 A OA 10153A OA 60657 A OA60657 A OA 60657A OA 60657 A OA60657 A OA 60657A OA 10153 A OA10153 A OA 10153A
- Authority
- OA
- OAPI
- Prior art keywords
- ions
- parts
- oak bark
- composition
- rubidium
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 46
- 241000219492 Quercus Species 0.000 title claims abstract description 43
- 239000000284 extract Substances 0.000 title abstract description 35
- 229910001419 rubidium ion Inorganic materials 0.000 claims abstract description 11
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229910001424 calcium ion Inorganic materials 0.000 claims abstract description 9
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229910001414 potassium ion Inorganic materials 0.000 claims abstract description 7
- 230000001225 therapeutic effect Effects 0.000 claims abstract description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 201000004681 Psoriasis Diseases 0.000 claims description 6
- 229910003480 inorganic solid Inorganic materials 0.000 claims description 6
- 239000003937 drug carrier Substances 0.000 claims description 5
- 239000006286 aqueous extract Substances 0.000 claims 4
- 238000011282 treatment Methods 0.000 abstract description 15
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract description 6
- 229910052717 sulfur Inorganic materials 0.000 abstract description 6
- 239000011593 sulfur Substances 0.000 abstract description 6
- 230000001154 acute effect Effects 0.000 abstract description 4
- 208000000453 Skin Neoplasms Diseases 0.000 abstract description 2
- 206010040943 Skin Ulcer Diseases 0.000 abstract description 2
- 231100000019 skin ulcer Toxicity 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000002674 ointment Substances 0.000 description 26
- CPRMKOQKXYSDML-UHFFFAOYSA-M rubidium hydroxide Chemical compound [OH-].[Rb+] CPRMKOQKXYSDML-UHFFFAOYSA-M 0.000 description 18
- 239000000243 solution Substances 0.000 description 16
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 15
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 12
- 239000012153 distilled water Substances 0.000 description 11
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 10
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 10
- 239000000920 calcium hydroxide Substances 0.000 description 10
- 235000011116 calcium hydroxide Nutrition 0.000 description 10
- 229940095643 calcium hydroxide Drugs 0.000 description 10
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 10
- CUBCNYWQJHBXIY-UHFFFAOYSA-N benzoic acid;2-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=CC=C1.OC(=O)C1=CC=CC=C1O CUBCNYWQJHBXIY-UHFFFAOYSA-N 0.000 description 9
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 9
- 229910000368 zinc sulfate Inorganic materials 0.000 description 9
- 229960001763 zinc sulfate Drugs 0.000 description 9
- 208000025865 Ulcer Diseases 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- 231100000397 ulcer Toxicity 0.000 description 7
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- 240000004885 Quercus rubra Species 0.000 description 6
- 235000009135 Quercus rubra Nutrition 0.000 description 6
- 229940093956 potassium carbonate Drugs 0.000 description 6
- 229910000027 potassium carbonate Inorganic materials 0.000 description 6
- 235000011181 potassium carbonates Nutrition 0.000 description 6
- 239000005711 Benzoic acid Substances 0.000 description 5
- 238000005299 abrasion Methods 0.000 description 5
- 229960004365 benzoic acid Drugs 0.000 description 5
- 235000010233 benzoic acid Nutrition 0.000 description 5
- 229920002562 Polyethylene Glycol 3350 Polymers 0.000 description 4
- 229920002565 Polyethylene Glycol 400 Polymers 0.000 description 4
- 239000002202 Polyethylene glycol Substances 0.000 description 4
- 206010037888 Rash pustular Diseases 0.000 description 4
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 4
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- JLFNLZLINWHATN-UHFFFAOYSA-N pentaethylene glycol Chemical compound OCCOCCOCCOCCOCCO JLFNLZLINWHATN-UHFFFAOYSA-N 0.000 description 4
- 229920001223 polyethylene glycol Polymers 0.000 description 4
- 208000029561 pustule Diseases 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 201000002282 venous insufficiency Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 208000004210 Pressure Ulcer Diseases 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 3
- 230000029663 wound healing Effects 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- 206010004146 Basal cell carcinoma Diseases 0.000 description 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 2
- 206010020649 Hyperkeratosis Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 206010023347 Keratoacanthoma Diseases 0.000 description 2
- 208000001126 Keratosis Diseases 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 206010042496 Sunburn Diseases 0.000 description 2
- 241000159241 Toxicodendron Species 0.000 description 2
- 241000159243 Toxicodendron radicans Species 0.000 description 2
- 241000871311 Toxicodendron vernix Species 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 201000001441 melanoma Diseases 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- 206010041823 squamous cell carcinoma Diseases 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- 235000014692 zinc oxide Nutrition 0.000 description 2
- 229960001296 zinc oxide Drugs 0.000 description 2
- 241000242759 Actiniaria Species 0.000 description 1
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 1
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 1
- 102000004452 Arginase Human genes 0.000 description 1
- 108700024123 Arginases Proteins 0.000 description 1
- 102000003846 Carbonic anhydrases Human genes 0.000 description 1
- 108090000209 Carbonic anhydrases Proteins 0.000 description 1
- 102000005367 Carboxypeptidases Human genes 0.000 description 1
- 108010006303 Carboxypeptidases Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 108010071840 Cytosol nonspecific dipeptidase Proteins 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010017533 Fungal infection Diseases 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- 102000030789 Histidine Ammonia-Lyase Human genes 0.000 description 1
- 108700006308 Histidine ammonia-lyases Proteins 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 208000007766 Kaposi sarcoma Diseases 0.000 description 1
- 208000031888 Mycoses Diseases 0.000 description 1
- 108010068563 PepT tripeptidase Proteins 0.000 description 1
- 102000015439 Phospholipases Human genes 0.000 description 1
- 108010064785 Phospholipases Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000006311 Pyoderma Diseases 0.000 description 1
- 206010039491 Sarcoma Diseases 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 108010070926 Tripeptide aminopeptidase Proteins 0.000 description 1
- 206010067653 Tropical ulcer Diseases 0.000 description 1
- QCWXUUIWCKQGHC-UHFFFAOYSA-N Zirconium Chemical compound [Zr] QCWXUUIWCKQGHC-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- -1 aluminum ions Chemical class 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- BZRRQSJJPUGBAA-UHFFFAOYSA-L cobalt(ii) bromide Chemical compound Br[Co]Br BZRRQSJJPUGBAA-UHFFFAOYSA-L 0.000 description 1
- 230000036570 collagen biosynthesis Effects 0.000 description 1
- 230000000536 complexating effect Effects 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 229910001411 inorganic cation Inorganic materials 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 229910000358 iron sulfate Inorganic materials 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 239000003883 ointment base Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000001823 pruritic effect Effects 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229910052726 zirconium Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/49—Fagaceae (Beech family), e.g. oak or chestnut
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Oncology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Chemical And Physical Treatments For Wood And The Like (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicinal Preparation (AREA)
- Road Paving Structures (AREA)
- Laminated Bodies (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US97307192A | 1992-11-06 | 1992-11-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| OA10153A true OA10153A (en) | 1996-12-18 |
Family
ID=25520460
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| OA60657A OA10153A (en) | 1992-11-06 | 1995-05-05 | Compositions of oak bark extract related synthetic compositions and method of using same |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US6149947A (de) |
| EP (1) | EP0668769B1 (de) |
| JP (1) | JP3640215B2 (de) |
| AT (1) | ATE191850T1 (de) |
| AU (1) | AU700019B2 (de) |
| BR (1) | BR9307401A (de) |
| CA (1) | CA2148795C (de) |
| CY (1) | CY2231B1 (de) |
| CZ (1) | CZ117395A3 (de) |
| DE (1) | DE69328438T2 (de) |
| DK (1) | DK0668769T3 (de) |
| ES (1) | ES2147780T3 (de) |
| HU (1) | HUT73791A (de) |
| MX (1) | MX9306960A (de) |
| NO (1) | NO951740L (de) |
| NZ (1) | NZ258019A (de) |
| OA (1) | OA10153A (de) |
| PL (1) | PL308770A1 (de) |
| PT (1) | PT668769E (de) |
| WO (1) | WO1994011010A2 (de) |
| ZA (1) | ZA938274B (de) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7014870B1 (en) * | 1992-11-06 | 2006-03-21 | Greystone Medical Group, Inc. | Compositions of oak bark extract related synthetic compositions and method of using same |
| AUPN104895A0 (en) * | 1995-02-10 | 1995-03-09 | Lai, John | Methods of and preparations for the treatment of ailments and disorders |
| US20040037898A1 (en) * | 1997-10-08 | 2004-02-26 | Hon David N.S | Compositions of oak bark extract, related synthetic compositions and method of using same |
| RU2125460C1 (ru) * | 1997-11-17 | 1999-01-27 | Закрытое акционерное общество научно-производственная фирма "Новь" | Биостимулирующее средство |
| US20050033251A1 (en) * | 1998-12-08 | 2005-02-10 | Quick-Med Technologies, Inc. | Controlled release of biologically active substances from select substrates |
| US20040170703A1 (en) * | 2001-11-29 | 2004-09-02 | Greystone Medical Group, Inc. | Reduction of reactive oxygen species in chronic wound management |
| MXPA04005219A (es) * | 2001-11-29 | 2005-06-20 | Greystone Medical Group Inc | Tratamiento de heridas y composiciones empleadas. |
| US6667026B1 (en) | 2002-03-15 | 2003-12-23 | Pocono Falls, Inc. | Allergic contact dermatitis treatment and composition therefor |
| US20040023937A1 (en) * | 2002-05-24 | 2004-02-05 | Greystone Medical Group, Inc. | Anti-cancer formulation |
| CA2511440A1 (en) * | 2002-12-23 | 2004-07-15 | Greystone Medical Group, Inc. | Reduction of reactive oxygen species in chronic wound management |
| WO2005000328A1 (en) * | 2003-06-24 | 2005-01-06 | Zanti Gianfranco | Compositions based on plant ash for the treatment of skin diseases |
| AU2005258225A1 (en) * | 2004-06-22 | 2006-01-05 | Greystone Medical Group, Inc. | Methods for treatment of wounds using time release compositions |
| US7687650B2 (en) | 2006-02-03 | 2010-03-30 | Jr Chem, Llc | Chemical compositions and methods of making them |
| US7897800B2 (en) | 2006-02-03 | 2011-03-01 | Jr Chem, Llc | Chemical compositions and methods of making them |
| WO2007089267A1 (en) | 2006-02-03 | 2007-08-09 | Jr Chem, Llc | Anti-aging treatment using copper and zinc compositions |
| US7867522B2 (en) | 2006-09-28 | 2011-01-11 | Jr Chem, Llc | Method of wound/burn healing using copper-zinc compositions |
| US8894599B2 (en) | 2007-03-15 | 2014-11-25 | Om Kataria | Uterine stimulant sticks |
| EP3939599A3 (de) | 2007-10-15 | 2022-03-16 | HS Pharmaceuticals, LLC | Silikathaltige zusammensetzungen und verfahren zur behandlung |
| US8273791B2 (en) | 2008-01-04 | 2012-09-25 | Jr Chem, Llc | Compositions, kits and regimens for the treatment of skin, especially décolletage |
| US20160184354A1 (en) | 2009-01-23 | 2016-06-30 | Jr Chem, Llc | Rosacea treatments and kits for performing them |
| US20110200655A1 (en) * | 2010-02-16 | 2011-08-18 | Michael Darryl Black | Systems and methods that kill infectious agents (bacteria) without the use of a systemic anti-biotic |
| US8952057B2 (en) | 2011-01-11 | 2015-02-10 | Jr Chem, Llc | Compositions for anorectal use and methods for treating anorectal disorders |
| US8828449B2 (en) | 2012-01-26 | 2014-09-09 | Libby Robinson | Wound dressing composition and method of use |
| US9351995B1 (en) | 2011-04-29 | 2016-05-31 | Red Oax Holdings, LLC | Compositions and methods of enhancing wound healing |
| WO2013012968A1 (en) | 2011-07-20 | 2013-01-24 | 3M Innovative Properties Company | Dressing with ion-carrying composition |
| JP6133858B2 (ja) * | 2011-07-28 | 2017-05-24 | スリーエム イノベイティブ プロパティズ カンパニー | 創傷治癒組成物及び使用方法 |
| US9907702B2 (en) | 2011-08-17 | 2018-03-06 | 3M Innovative Properties Company | Monomer-grafted fibers and uses thereof |
| GB201402672D0 (en) | 2014-02-14 | 2014-04-02 | Medical Res Council | Materials and methods relating to stabilised polymeric silicate compositions |
| WO2016123539A1 (en) | 2015-01-29 | 2016-08-04 | Wardell Mark R | Wound healing compositions involving medicinal honey, mineral ions, and methylglyoxal, and methods of use |
| AU2019433065B2 (en) * | 2019-03-04 | 2022-08-18 | Aurealis Therapeutics AG | Chloride-inducible prokaryotic expression system |
| IT201900018047A1 (it) * | 2019-10-07 | 2021-04-07 | Nello Vallicella | Procedimento per la preparazione di una composizione topica liquida. |
| WO2024196897A1 (en) * | 2023-03-22 | 2024-09-26 | Courtland Imel | Novel methods for increasing healing speed of human and animal wounds |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US55911A (en) * | 1866-06-26 | Improved medical compound | ||
| US37901A (en) * | 1863-03-17 | Improved liniment | ||
| US202246A (en) * | 1878-04-09 | Improvement in medical compounds | ||
| US256847A (en) * | 1882-04-25 | Salve | ||
| DE819127C (de) * | 1949-09-28 | 1951-10-29 | Heinz Dr Bauer | Verfahren zur Herstellung eines Heilbades gegen Hautekzeme |
| DE812341C (de) * | 1950-03-07 | 1951-08-27 | Penicillin Ges Dauelsberg & Co | Verfahren zur Herstellung eines Hautbehandlungsmittels |
| DE833840C (de) * | 1950-06-01 | 1952-03-13 | Dr Heinz Bauer | Verfahren zur Herstellung einer Salbe gegen Hautekzeme |
| US3928584A (en) * | 1969-06-30 | 1975-12-23 | Us Health Education & Welfare | Extracts from active tree saps for treating P388 mouse leukemia |
| US4059695A (en) * | 1974-02-14 | 1977-11-22 | Kanari Hirosaki | Method for manufacturing a tonic composition for man and other animals |
| JPS60164467A (ja) * | 1984-02-07 | 1985-08-27 | Rooman Kogyo:Kk | 飲料 |
| EP0217975B1 (de) * | 1985-10-08 | 1991-12-04 | Psori-Med Ag | Salzmischung zur Behandlung der Schuppenflechte (Psoriasis) und anderer Hautkrankheiten |
| US4847083A (en) * | 1986-04-02 | 1989-07-11 | Dermasciences, Inc. | Two-step procedure for indolent wound healing and aqueous medium and topical ointment used in connection therewith |
| BE1000950A3 (fr) * | 1987-10-05 | 1989-05-23 | Claude Patricia | Produit de beaute saliaris au sel de la mer morte et a l'argile verte de haute provence. |
| AT393221B (de) * | 1988-02-03 | 1991-09-10 | Leopold Pharma Gmbh | Mittel mit zerstoerender wirkung auf maligne tumore, verfahren zu dessen herstellung und praeparation zur anwendung in der therapie von krebskranken |
| US5080900A (en) * | 1990-04-17 | 1992-01-14 | Stanley R Thomas | Treatment of skin ulcers with an aqueous extract of oak bark ash |
-
1993
- 1993-11-04 PT PT94900557T patent/PT668769E/pt unknown
- 1993-11-04 DK DK94900557T patent/DK0668769T3/da active
- 1993-11-04 JP JP51222794A patent/JP3640215B2/ja not_active Expired - Fee Related
- 1993-11-04 EP EP94900557A patent/EP0668769B1/de not_active Expired - Lifetime
- 1993-11-04 AU AU55500/94A patent/AU700019B2/en not_active Ceased
- 1993-11-04 HU HU9501323A patent/HUT73791A/hu active IP Right Revival
- 1993-11-04 AT AT94900557T patent/ATE191850T1/de not_active IP Right Cessation
- 1993-11-04 WO PCT/US1993/010670 patent/WO1994011010A2/en not_active Ceased
- 1993-11-04 PL PL93308770A patent/PL308770A1/xx unknown
- 1993-11-04 BR BR9307401A patent/BR9307401A/pt not_active Application Discontinuation
- 1993-11-04 ES ES94900557T patent/ES2147780T3/es not_active Expired - Lifetime
- 1993-11-04 DE DE69328438T patent/DE69328438T2/de not_active Expired - Lifetime
- 1993-11-04 NZ NZ258019A patent/NZ258019A/xx not_active IP Right Cessation
- 1993-11-04 CA CA002148795A patent/CA2148795C/en not_active Expired - Fee Related
- 1993-11-04 CZ CZ951173A patent/CZ117395A3/cs unknown
- 1993-11-05 ZA ZA938274A patent/ZA938274B/xx unknown
- 1993-11-08 MX MX9306960A patent/MX9306960A/es not_active IP Right Cessation
-
1995
- 1995-05-04 NO NO951740A patent/NO951740L/no unknown
- 1995-05-05 OA OA60657A patent/OA10153A/en unknown
-
1997
- 1997-10-08 US US08/947,055 patent/US6149947A/en not_active Expired - Fee Related
-
2001
- 2001-08-31 CY CY0100022A patent/CY2231B1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUT73791A (en) | 1996-09-30 |
| AU700019B2 (en) | 1998-12-17 |
| CY2231B1 (en) | 2003-04-18 |
| NO951740D0 (no) | 1995-05-04 |
| EP0668769B1 (de) | 2000-04-19 |
| CZ117395A3 (en) | 1995-11-15 |
| ES2147780T3 (es) | 2000-10-01 |
| DE69328438T2 (de) | 2001-01-04 |
| HU9501323D0 (en) | 1996-05-28 |
| EP0668769A1 (de) | 1995-08-30 |
| JPH08503462A (ja) | 1996-04-16 |
| BR9307401A (pt) | 1999-08-24 |
| CA2148795A1 (en) | 1994-05-26 |
| NO951740L (no) | 1995-06-19 |
| AU5550094A (en) | 1994-06-08 |
| ATE191850T1 (de) | 2000-05-15 |
| MX9306960A (es) | 1995-01-31 |
| US6149947A (en) | 2000-11-21 |
| PL308770A1 (en) | 1995-08-21 |
| PT668769E (pt) | 2000-10-31 |
| WO1994011010A3 (en) | 1994-09-15 |
| NZ258019A (en) | 1998-12-23 |
| CA2148795C (en) | 2004-08-10 |
| JP3640215B2 (ja) | 2005-04-20 |
| WO1994011010A2 (en) | 1994-05-26 |
| ZA938274B (en) | 1994-06-09 |
| DK0668769T3 (da) | 2000-10-02 |
| DE69328438D1 (de) | 2000-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2148795C (en) | Compositions of oak bark extract, related synthetic compositions, and method of using same | |
| US7014870B1 (en) | Compositions of oak bark extract related synthetic compositions and method of using same | |
| US4512978A (en) | Dermatological composition useful in the treatment of psoriasis | |
| US4512977A (en) | Therapeutic selenium compositions and the use thereof | |
| JP6495183B2 (ja) | 表面の創傷を処置するための組成物および方法 | |
| US3943248A (en) | Methods of treating burns using colophony containing preparations | |
| EA004537B1 (ru) | Композиция на основе аскорбиновой кислоты и способ лечения стареющей или поврежденной кожи | |
| US5420114A (en) | Methods for the treatment of skin disorders | |
| CA2431651A1 (en) | Antifungal nail composition and method of use | |
| CN1108786C (zh) | 银箔化妆品 | |
| CA1112164A (en) | Therapeutic selenium compositions and the use thereof | |
| US4340590A (en) | Method for reducing or inhibiting ecchymosis in skin tissues with inorganic selenium compositions | |
| US20060246154A1 (en) | Composition of oak bark extract, related synthetic compositions, and method of using same | |
| US5616619A (en) | Topical composition for burn relief and method of use | |
| US20040037898A1 (en) | Compositions of oak bark extract, related synthetic compositions and method of using same | |
| CN105169463B (zh) | 一种阳离子婴儿医用敷料及其制备方法 | |
| JPS6054932B2 (ja) | 治療組成物 | |
| CA2126704C (en) | Dermatological compositions and methods for the treatment of skin therewith | |
| RU2155586C2 (ru) | Средство для заживления ран, ожогов и язв | |
| JP2766811B2 (ja) | 水性皮膚外用剤 | |
| MXPA03002092A (es) | Solucion topica terapeutica para la piel y metodo asociado de uso. | |
| AU687840B2 (en) | Topical composition for burn relief and method of use | |
| CA2100314C (en) | Pharmaceutical composition for the treatment of chronic skin ulcers | |
| JPH1143433A (ja) | グルコノデルタラクトンまたはグルコン酸を含む性ホルモン過多症用皮膚外用剤 | |
| Zeligman | Topical chlorophyll therapy in the dermatoses |